May 18, 2018 / 12:26 PM / 3 months ago

BRIEF-Ligand Prices Offering Of $650 Mln Of Convertible Senior Notes

May 18 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND PRICES OFFERING OF $650 MILLION OF CONVERTIBLE SENIOR NOTES

* LIGAND PHARMACEUTICALS INC - PRICING OF $650 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0.75% CONVERTIBLE SENIOR NOTES DUE 2023

* LIGAND PHARMACEUTICALS INC - CONVERSION RATE FOR NOTES WILL INITIALLY BE 4.0244 SHARES PER $1,000 PRINCIPAL AMOUNT OF NOTES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below